When the early Covid vaccine trial results came out, an important indicator of success couldn’t yet be assessed: durability. Those initial studies were just three to four months — too short to ...
Animal studies indicate that a new COVID-19 vaccine developed at Rutgers may provide more durable protection against SARS-CoV-2 and its emerging variants than existing vaccines. "We need a better ...